XML 35 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 218,044 $ 293,477
Short-term marketable securities 1,118,171 571,930
Cost sharing reimbursements due from related party 0 1,226
Prepaid expenses and other current assets 36,104 30,601
Total current assets 1,372,319 897,234
Long-term marketable securities 0 425,449
Property and equipment, net 44,087 38,865
Operating lease right-of-use assets 30,437 30,743
Other non-current assets 13,399 11,871
Total assets 1,460,242 1,404,162
Current liabilities:    
Accounts payable 2,790 4,779
Cost sharing payments due to related party 4,388 0
Accrued expenses and other current liabilities 66,691 53,165
Related party contract liability, current 290,053 292,386
Contract liabilities, current 0 27,915
Total current liabilities 363,922 378,245
Related party contract liability, less current portion 479 1,295
Contract liabilities, less current portion 0 3,398
Operating lease liabilities, less current portion 53,032 58,554
Other non-current liabilities 379 379
Total liabilities 417,812 441,871
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Convertible preferred stock, $0.01 par value; 40,000,000 shares authorized as of December 31, 2022 and December 31, 2021; 0 shares issued and outstanding as of December 31, 2022 and December 31, 2021 0 0
Common stock, $0.01 par value; 400,000,000 shares authorized as of December 31, 2022 and December 31, 2021; 135,965,918 and 122,283,305 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively 1,686 1,548
Additional paid-in capital 2,018,617 1,608,238
Accumulated other comprehensive loss (6,886) (2,499)
Accumulated deficit (970,987) (644,996)
Total stockholders’ equity 1,042,430 962,291
Total liabilities and stockholders’ equity $ 1,460,242 $ 1,404,162